Journal of Pharmacological Reports
Open Access

Uppsala Monitoring Centre, Sweden

Biography

Pharmacist working as a researcher with 10 years of experience in the UMC Research Department.

Personal responsibilities include analysis of adverse drug reaction reports for potential signals as well as writing and editing signals shared with the national authorities within the WHO Program for International Drug Monitoring. Also author scientific publications as well as project lead and educate in Pharmacovigilance and Drug Safety in various courses in a global setting.

Publications

• Commentary   
  Combined Evidence from Individual Cases over Half a Hundred Years Collected Globally
  Author(s): Sarah Watson*
  
  Adverse drug reactions (ADRs) are a crucial explanation for morbidity and mortality. Reports on differences in reporting patterns between women and men exist nationally. The goal of this study was to assess the worldwide evidence on spontaneous post-marketing ADR reporting differences be- tween reports for ladies and men. Methods: We analysed data collected within VigiBase, the WHO global database of individual case safety reports, between 1967-2 January 2018. VigiBase contains quite 18 million reports from the 131 mem- ber countries of the WHO Programme for International Drug Monitoring. Findings: Of the reports with information on sex, 9,056,566 (60.1%) concerned female and 6,012,804 (39.9%) male children and adults. More female ADR reports were submitted altogether regions of the planet and by all kinds of reporters. A higher proportion of female reports was seen altogether age bra.. View More»
  DOI: 10.35248/jpr.22.6.163

  Abstract HTML PDF